{"entity":{"type":"insider","cik":"0001429932","url":"/insider/0001429932","json_url":"/insider/0001429932.json","name":"Elston George","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2016-08-31","last":"2020-09-09","span_basis":"filed_date"},"name_variants":[{"name":"Elston George","source":"filing","n_filings":5,"first_seen":"2016-08-31","last_seen":"2020-09-09"}],"transactions":[{"id":2163283,"accession":"0001562180-20-005930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-005930","line_url":"/filing/0001562180-20-005930#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001429932","owner_name":"Elston George","owner_display_name":"Elston George","owner_url":"/insider/0001429932","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-09","scope":"insider"},{"id":2366407,"accession":"0001562180-20-005659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-005659","line_url":"/filing/0001562180-20-005659#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001429932","owner_name":"Elston George","owner_display_name":"Elston George","owner_url":"/insider/0001429932","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.6112,"price_display":"0.61","price_state":"stated","total_value":6112.0,"total_display":"6,112.00","total_whole":"6,112","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-26","scope":"insider"},{"id":2918872,"accession":"0001562180-20-002451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-002451","line_url":"/filing/0001562180-20-002451#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001429932","owner_name":"Elston George","owner_display_name":"Elston George","owner_url":"/insider/0001429932","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","total_whole":"9,600","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-12","filed_date":"2020-03-13","scope":"insider"},{"id":7854851,"accession":"0001562180-19-005548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005548","line_url":"/filing/0001562180-19-005548#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001429932","owner_name":"Elston George","owner_display_name":"Elston George","owner_url":"/insider/0001429932","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.429,"price_display":"1.43","price_state":"stated","total_value":14290.0,"total_display":"14,290.00","total_whole":"14,290","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-18","scope":"insider"},{"id":3335866,"accession":"0001382963-16-000234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-16-000234","line_url":"/filing/0001382963-16-000234#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"JUNIPER PHARMACEUTICALS INC","issuer_ticker":"JNP","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001429932","owner_name":"Elston George","owner_display_name":"Elston George","owner_url":"/insider/0001429932","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"common stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":5500.0,"total_display":"5,500.00","total_whole":"5,500","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-31","filed_date":"2016-08-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2019-11-18","last_seen":"2020-09-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000821995","name":"JUNIPER PHARMACEUTICALS INC","url":"/issuer/0000821995","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2016-08-31","last_seen":"2016-08-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001429932","retrieved_at":"2026-08-27T17:58:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}